125 related articles for article (PubMed ID: 34854425)
1. Polymorphism of interleukin-6 -174 G/C (rs1800795) & the corresponding interleukin-6 level as a prognostic marker of cervical cancer.
Wagh P; Kulkarni P; Kerkar S; Tongaonkar H; Chaudhari H; Warke H; Deodhar K; Rekhi B; Mania-Pramanik J
Indian J Med Res; 2021 Aug; 154(2):391-398. PubMed ID: 34854425
[TBL] [Abstract][Full Text] [Related]
2. IL-6 597A/G (rs1800797) and 174G/C (rs1800795) Gene Polymorphisms in the Development of Cervical Cancer in Lithuanian Women.
Vitkauskaite A; Celiesiute J; Juseviciute V; Jariene K; Skrodeniene E; Samuolyte G; Nadisauskiene RJ; Vaitkiene D
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684062
[TBL] [Abstract][Full Text] [Related]
3. Molecular Investigation of the Association Among Common Interleukin-6 Polymorphism and Human Papillomavirus Genotypes with Cervical Cancer Among Iranian Women.
Pourroostaei Ardakani P; Abkhiz S; Sheykhi K; Adhami Mojarad K; Rahimi B; Panahi M; Hooshmand M
Monoclon Antib Immunodiagn Immunother; 2023 Aug; 42(4):125-131. PubMed ID: 37624608
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in cytotoxic T-lymphocyte associated antigen 4 gene does not affect scytotoxic T-lymphocyte associated antigen 4 levels in human papillomavirus-infected women with or without cervical cancer.
Wagh P; Kulkarni P; Kerkar S; Warke H; Chaudhari H; Deodhar K; Rekhi B; Tongaonkar H; Mania-Pramanik J
Indian J Med Microbiol; 2018; 36(2):207-210. PubMed ID: 30084412
[TBL] [Abstract][Full Text] [Related]
5. Killer cell immunoglobulin-like receptor (KIR) gene contents: Are they associated with cervical cancer?
Tembhurne AK; Maheshwari A; Warke H; Chaudhari H; Kerkar SC; Deodhar K; Rekhi B; Mania-Pramanik J
J Med Virol; 2023 Jan; 95(1):e27873. PubMed ID: 35593263
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the interleukin 6 gene and additional gene-gene interaction contribute to cervical cancer susceptibility in Eastern Chinese women.
Pu X; Gu Z; Wang X
Arch Gynecol Obstet; 2016 Nov; 294(6):1305-1310. PubMed ID: 27535759
[TBL] [Abstract][Full Text] [Related]
7. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms in tumor necrosis factor alpha and interleukin-10 are associated with an increased risk of cervical cancer.
Du GH; Wang JK; Richards JR; Wang JJ
Int Immunopharmacol; 2019 Jan; 66():154-161. PubMed ID: 30453149
[TBL] [Abstract][Full Text] [Related]
9. Association of
Duan HX; Chen YY; Shi JZ; Ren NN; Li XJ
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135142
[TBL] [Abstract][Full Text] [Related]
10. Serum Interleukin-6 Level and the rs1800795 Polymorphism in its Gene Associated with Neuroblastoma Risk in Chinese Children.
Zhao Q; Jin M; Zhang DW; Zhao W; Wang XS; Yue ZX; Duan C; Huang C; Ma XL
Chin Med J (Engl); 2018 May; 131(9):1075-1078. PubMed ID: 29692379
[TBL] [Abstract][Full Text] [Related]
11. Association Between the IL-6 rs1800795 Polymorphism and the Risk of Cervical Cancer: A Meta-Analysis of 1210 Cases and 1525 Controls.
Liu H; Lyu D; Zhang Y; Sheng L; Tang N
Technol Cancer Res Treat; 2017 Oct; 16(5):662-667. PubMed ID: 27777338
[TBL] [Abstract][Full Text] [Related]
12. Association of IL-6 promoter polymorphism hotspots (- 174G/C and - 572G/C) with cardiovascular disease risk factors.
Tabrez S; Jabir NR; Zughaibi TA; Suhail M
Mol Biol Rep; 2022 Mar; 49(3):2265-2272. PubMed ID: 35023009
[TBL] [Abstract][Full Text] [Related]
13. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
14. Evaluating interleukin-6 levels and the rs1800795 variant in Turkish patients with COVID-19: a prospective cohort study.
Sezer O; Nursal AF; Gunal O; Gorgun S; Tekcan A; Unluguzel Ustun G; Yigit S
Nucleosides Nucleotides Nucleic Acids; 2024; 43(4):377-390. PubMed ID: 37787093
[TBL] [Abstract][Full Text] [Related]
15. Predisposition to HPV16/18-related cervical cancer because of proline homozygosity at codon 72 of p53 among Indian women is influenced by HLA-B*07 and homozygosity of HLA-DQB1*03.
Bhattacharya P; Sengupta S
Tissue Antigens; 2007 Oct; 70(4):283-93. PubMed ID: 17767549
[TBL] [Abstract][Full Text] [Related]
16. Significant association between IL10-1082/-819 and TNF-308 haplotypes and the susceptibility to cervical carcinogenesis in women infected by Human papillomavirus.
Chagas BS; Lima RCP; Paiva Júnior SSL; Silva RCO; Cordeiro MN; Silva Neto JDC; Batista MVA; Silva AJD; Gurgel APAD; Freitas AC
Cytokine; 2019 Jan; 113():99-104. PubMed ID: 29935877
[TBL] [Abstract][Full Text] [Related]
17. The protective role of the -1306C>T functional polymorphism in matrix metalloproteinase-2 gene is associated with cervical cancer: implication of human papillomavirus infection.
Singh N; Hussain S; Sharma U; Suri V; Nijhawan R; Bharadwaj M; Sobti RC
Tumour Biol; 2016 Apr; 37(4):5295-303. PubMed ID: 26561467
[TBL] [Abstract][Full Text] [Related]
18. IL-10 gene polymorphism c.-592C>A increases HPV infection susceptibility and influences IL-10 levels in HPV infected women.
Berti FCB; Pereira APL; Trugilo KP; Cebinelli GCM; Silva LFDRS; Lozovoy MAB; Simão ANC; Watanabe MAE; de Oliveira KB
Infect Genet Evol; 2017 Sep; 53():128-134. PubMed ID: 28552689
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia.
Zakharyan R; Petrek M; Arakelyan A; Mrazek F; Atshemyan S; Boyajyan A
Tissue Antigens; 2012 Aug; 80(2):136-42. PubMed ID: 22571276
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of interleukin-6 single nucleotide polymorphism genotypes in neuroblastoma: rs1800795 (promoter) and rs8192284 (receptor).
Lagmay JP; London WB; Gross TG; Termuhlen A; Sullivan N; Axel A; Mundy B; Ranalli M; Canner J; McGrady P; Hall B
Clin Cancer Res; 2009 Aug; 15(16):5234-9. PubMed ID: 19671870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
